Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
LOADING
|||
ROE: Strong Returns
Trending higher, above historical average, slight contraction.
Left:
||||
Return on equity
Latest
-49.18%
↑ 16% above average
Average (6y)
-58.80%
Historical baseline
Range
High:-38.19%
Low:-85.05%
CAGR
-8.7%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | -49.18% | +26.4% |
| 2023 | -66.82% | -22.4% |
| 2022 | -54.59% | -25.2% |
| 2021 | -43.61% | -14.2% |
| 2020 | -38.19% | +48.5% |
| 2019 | -74.13% | +12.8% |
| 2018 | -85.05% | - |